Biomarin Pharmaceutical Inc at JPMorgan US All-Stars Conference (Virtual) Transcript
All right. I think we are live here now. So good morning or good afternoon. I guess even good evening to some of you. My name is Cory Kasimov, I'm a Senior Biotech Analyst at JPMorgan. And it's my pleasure to host this next session at the 11th Annual, but first time virtual, U.S. All stars Conference with BioMarin. And here from the company, we have J.J. Bienaimé, the Chairman and CEO; Hank Fuchs, President of Worldwide R&D; and Brian Mueller, the newly appointed CFO.
So in terms of structure, in just a minute, I'm going to turn things over to J.J. and Hank for some opening comments from management. Then I'll run through a bunch of my questions. But remember, you also have the ability to ask questions with a function on your webcast, so feel free to send those in throughout, and we'll work them into the conversation.
So with that, let me hand it over to J.J. and Hank for some opening comments to kick things off here.
-©,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
